RTT is a monogenetic progressive neurologic disorder that shares proposed mechanistic and core symptoms with ASD, with mutations in the X-linked gene MeCP2 occurring in ~90% of patients with RTT (46–48). This evidence concerns the gene MECP2 and Rett syndrome.